Evaluating a multifaceted implementation strategy and package of evidence-based interventions based on WHO PEN for people living with HIV and cardiometabolic conditions in Lusaka, Zambia: protocol for the TASKPEN hybrid efectiveness-implementation stepped wedge cluster randomized trial
Files
Date
2024
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Implementation Science Communications
Abstract
Background Despite increasing morbidity and mortality from non-communicable diseases (NCD) globally, health
systems in low- and middle-income countries (LMICs) have limited capacity to address these chronic conditions,
particularly in sub-Saharan Africa (SSA). There is an urgent need, therefore, to respond to NCDs in SSA, beginning
by applying lessons learned from the first global response to any chronic disease—HIV—to tackle the leading
cardiometabolic killers of people living with HIV (PLHIV). We have developed a feasible and acceptable package
of evidence-based interventions and a multi-faceted implementation strategy, known as“TASKPEN,” that has been
adapted to the Zambian setting to address hypertension, diabetes, and dyslipidemia. The TASKPEN multifaceted
implementation strategy focuses on reorganizing service delivery for integrated HIV-NCD care and features task shifting, practice facilitation, and leveraging HIV platforms for NCD care. We propose a hybrid type II effectiveness implementation stepped-wedge cluster randomized trial to evaluate the effects of TASKPEN on clinical and implementation outcomes, including dual control of HIV and cardiometabolic NCDs, as well as quality of life, intervention
reach, and cost-efectiveness Methods The trial will be conducted in 12 urban health facilities in Lusaka, Zambia over a 30-month period. Clinical
outcomes will be assessed via surveys with PLHIV accessing routine HIV services, and a prospective cohort of PLHIV
with cardiometabolic comorbidities nested within the larger trial. We will also collect data using mixed methods,
including in-depth interviews, questionnaires, focus group discussions, and structured observations, and estimate
cost-efectiveness through time-and-motion studies and other costing methods, to understand implementation outcomes according to Proctor’s Outcomes for Implementation Research, the Consolidated Framework for Implementation Research, and selected dimensions of RE-AIM.
Discussion Findings from this study will be used to make discrete, actionable, and context-specifc recommendations in Zambia and the region for integrating cardiometabolic NCD care into national HIV treatment programs. While
the TASKPEN study focuses on cardiometabolic NCDs in PLHIV, the multifaceted implementation strategy studied will
be relevant to other NCDs and to people without HIV. It is expected that the trial will generate new insights that enable the delivery of high-quality integrated HIV-NCD care, which may improve cardiovascular morbidity and viral suppression for PLHIV in SSA. This study was registered at ClinicalTrials.gov (NCT05950919).
Description
Research Article
Keywords
Non-communicable diseases, HIV/AIDS, Hypertension